Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Crispr Therapeutics Ag (CRSP)

Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Crispr Therapeutics Ag BAARERSTRASSE 14 ZUG V8 CH-6300 CHE

www.crisprtx.com P: 41-41-561-3277

Description:

CRISPR Therapeutics AG is a leading gene editing company focused on developing CRISPR/Cas9-based therapeutics. The company is rapidly leveraging its CRISPR/Cas9 gene-editing platform to make therapies for the treatment of hemoglobinopathies, cancer, diabetes and other diseases.

Key Statistics

Overview:

Market Capitalization, $K 4,767,030
Enterprise Value, $K 4,377,550
Shares Outstanding, K 84,883
Annual Sales, $ 371,210 K
Annual Net Income, $ -153,610 K
Last Quarter Sales, $ 201,210 K
Last Quarter Net Income, $ 89,350 K
EBIT, $ -222,540 K
EBITDA, $ -202,700 K
60-Month Beta 1.76
% of Insider Shareholders 4.10%
% of Institutional Shareholders 69.20%
Float, K 81,403
% Float 95.90%
Short Volume Ratio 0.66

Growth:

1-Year Return 2.94%
3-Year Return -55.62%
5-Year Return 36.91%
5-Year Revenue Growth 11,797.76%
5-Year Earnings Growth 43.60%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.10 on 02/21/24
Latest Earnings Date 05/13/24
Earnings Per Share ttm -1.96
EPS Growth vs. Prev Qtr 178.01%
EPS Growth vs. Prev Year 178.01%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CRSP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -8.09%
Return-on-Assets % -6.73%
Profit Margin % -41.38%
Debt/Equity 0.00
Price/Sales 12.70
Price/Cash Flow N/A
Price/Book 2.45
Book Value/Share 23.70
Interest Coverage -0.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar